CLS Patient Education & Adherence 2

Question 1

A patient with familial hypercholesterolemia is reluctant to start statin therapy due to fear of muscle side effects. What is the most evidence-based response?

Accepted Answer

Reassure that myopathy risk is low (~1 in 10,000) and offer lowest effective dose with monitoring

Answer

Serious myopathy with statins is rare (~1:10,000), and educating patients on actual risk versus perceived risk improves acceptance.

Question 2

Which counseling technique involves asking patients to repeat back key education points in their own words to assess understanding?

Accepted Answer

Teach-back method

Answer

The teach-back method verifies patient comprehension by having them explain information in their own words.

Question 3

A patient on high-intensity statin therapy asks why they need such a high dose when their LDL is only mildly elevated. Which explanation is most appropriate?

Accepted Answer

High-intensity statins are chosen based on cardiovascular risk category, not LDL level alone

Answer

Statin intensity is selected based on a patient's overall ASCVD risk category, not LDL elevation alone.

Question 4

Which of the following dietary modifications has the greatest evidence for reducing LDL-C in a non-pharmacologic patient education program?

Accepted Answer

Increasing dietary fiber and reducing saturated fat intake

Answer

Increasing soluble fiber and reducing saturated fat are the most evidence-based dietary strategies to lower LDL-C.

Question 5

A patient reports taking their statin every other day to 'give their liver a break.' What is the most important educational point?

Accepted Answer

Every-other-day dosing reduces cardiovascular benefit and is not recommended

Answer

Inconsistent statin dosing reduces cardiovascular benefit; daily dosing is required for optimal efficacy.

(CLS) Clinical Lipid Specialist Certification Practice Test

(CLS) Clinical Lipid Specialist Certification Practice Test

CLS Patient Education & Adherence 2